Abstract:Background/Aims: Genetic modification of mesenchymal stem cells (MSCs) is an essential requirement for their use as a delivery vehicle. To achieve higher transfection efficiency and better reproducibility than previously synthesized chitosan (100 kDa)-polyethylenimine (PEI; 1200 Da), we synthesized a low molecular weight PEI (1200 Da)-grafted chitosan (50 kDa) (CP). Methods: Safety of CP/DNA or PEI (25 kDa)/DNA was evaluated by an MTT assay using A549 cells or MSCs and a zebrafish embryo model. Effects of CP/DNA on the characteristics of MSCs were evaluated using flow cytometry. Additionally, a pGL3 plasmid was used to investigate the transfection efficiency of PEI (25 kDa), chitosan (100 kDa)-PEI (1200 Da), and CP with different N/P mass ratios on A549 cells and MSCs. Furthermore, CP/pGL3 was used to investigate the effect of serum on transfection, and intracellular transport was assessed by observing the intracellular location of DNA using laser scanning confocal microscopy. In addition, the effect of endocytosis on transfection efficiency was evaluated using A549 cells pre-treated with different inhibitors. Investigations related to analysis of transfection efficiency were all performed using the BCA protein assay to standardize the data. Furthermore, TGF-beta 1- and CXCR4-expressing plasmids were applied to evaluate the gene transfer efficiency of CP, including its effects on the osteogenic differentiation and migratory ability of MSCs. Results: The safety evaluation demonstrated that CP/DNA had significantly lower toxicity than PEI (25 kDa)/DNA. Additionally, DNA entered MSCs transfected by CP without changing their properties, while the examination of intracellular transport demonstrated that CP/pGL3 was internalized rapidly into MSCs. Furthermore, studies of the internalization mechanism showed that CP/pGL3 complexes entered the cells through caveolae-mediated endocytosis, thereby suggesting that the CP coating helped DNA enter A549 cells without the requirement for receptors. Compared to PEI (25 kDa), the interference of serum on transfection was reduced significantly with the use of CP in both A549 cells and MSCs. To evaluate the effects of gene delivery using the constructed CP complex and the possibility of obtaining gene-engineered MSCs, TGF-beta 1- and CXCR4-expressing plasmids were successfully delivered into MSCs, confirming their ability to induce osteogenesis and change the migratory ability of MSCs, respectively. Conclusion: These results demonstrated that CP could be used to deliver genes into MSCs and could potentially be used in gene therapy based on MSCs. (C) 2018 The Author(s) Published by S. Karger AG, Basel

Nonviral vector-based gene transfection of primary human skeletal myoblasts.

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells.

Lower-Molecular-Weight Chitosan-Treated Polyethyleneimine: a Practical Strategy For Gene Delivery to Mesenchymal Stem Cells.

Transplantation Of Novel Vascular Endothelial Growth Factor Gene Delivery System Manipulated Skeletal Myoblasts Promote Myocardial Repair

Efficient Gene Transfection into Mammalian Cells Mediated by Cross-linked Polyethylenimine

Efficiency of a high-titer retroviral vector for gene transfer into skeletal myoblasts

Manipulation of Transgene Expression in Fibroblast Cells by a Multifunctional Linear-Branched Hybrid Poly(β-Amino Ester) Synthesized Through an Oligomer Combination Approach.

Transplantation of Nanoparticle Transfected Skeletal Myoblasts Overexpressing Vascular Endothelial Growth Factor-165 for Cardiac Repair

Novel Hyperbranched Polyamidoamine Nanoparticles for Transfecting Skeletal Myoblasts with Vascular Endothelial Growth Factor Gene for Cardiac Repair

[A Experimental Study on Transfecting Human Stromal Cell-Derived Factor 1alpha and Human Vascular Endothelial Growth Factor 165 Genes into Myoblasts in Vitro].

Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle

Polyethylenimine-mediated Gene Delivery into Human Bone Marrow Mesenchymal Stem Cells from Patients

Innovative Strategy for 3D Transfection of Primary Human Stem Cells with BMP-2 Expressing Plasmid DNA: A Clinically Translatable Strategy for Ex Vivo Gene Therapy

Human VEGF165 Gene Transfected Adult Myoblasts in vitro

The Effectiveness, Cytotoxicity, and Intracellular Trafficking of Nonviral Vectors for Gene Delivery to Bone Mesenchymal Stem Cells

Enhanced fusion of myoblasts with myofibers for efficient gene delivery induced by a partially purified protein fraction from rat muscle extract.

Gene Transfer to Skeletal Muscle by Site-Specific Delivery of Electroporation and Ultrasound

Peptide-based Vector of VEGF Plasmid for Efficient Gene Delivery in Vitro and Vessel Formation in Vivo.

Evaluation of Transfection Efficiency of Novel Non-Viral Nano Gene Vector PEI-β-CyD on Chondrocytes and Bone Marrow-Derived Mesenchymal Stem Cells

Angiogenic Gene-Modified Myoblasts Promote Vascularization During Repair of Skeletal Muscle Defects